GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Researchers track Long-Term safety of Vision-Loss treatment
Disease control Recruiting nowThis study follows people who previously received an experimental eye injection treatment for geographic atrophy, a condition that causes progressive vision loss. The main goal is to monitor long-term safety and side effects of the treatment over time. Participants will receive r…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Diabetes drug repurposed in fight against leading cause of blindness
Disease control Recruiting nowThis study is testing if a daily pill called dapagliflozin, already used for diabetes, can slow the progression of an advanced form of age-related macular degeneration (AMD) called geographic atrophy (GA). About 70 adults with GA will take either the drug or a placebo for one yea…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test tiny eye implant to halt blinding disease
Disease control Recruiting nowThis study is testing whether a small implant placed under the retina can help preserve or improve vision in people with advanced dry age-related macular degeneration (AMD), a leading cause of vision loss. The trial will compare the implant against a simulated procedure in 24 par…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Regenerative Patch Technologies, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Monthly eye jabs tested to slow blinding disease
Disease control Recruiting nowThis study is checking the safety of a drug called ASP3021 for people in Japan with geographic atrophy, a condition that causes gradual, permanent vision loss. About 20 participants will receive a monthly injection of the drug directly into their affected eye for one year. The ma…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Experimental eye injection aims to halt vision loss in dry AMD
Disease control Recruiting nowThis early-stage study is testing whether a single injection called VOY-101 can slow the progression of advanced dry age-related macular degeneration (AMD), a condition that causes gradual central vision loss. Researchers will give increasing doses to 60 participants aged 60+ to …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New shot in the eye aims to slow blinding disease
Disease control Recruiting nowThis study is testing a new eye injection called ABBV-6628 for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes vision loss. The main goals are to check the safety of the injection and see how the body processes it. Researchers …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First human trial for new Vision-Loss injection begins
Disease control Recruiting nowThis is an early-stage study to test the safety and tolerability of a new experimental drug, RO7669330, given as an injection into the eye. It is for people with geographic atrophy, an advanced form of age-related macular degeneration that leads to permanent vision loss. The main…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test growing new eye cells from a Patient's own blood
Disease control Recruiting nowThis early-stage trial is testing the safety of a new procedure for advanced dry macular degeneration, a leading cause of vision loss. Researchers take a small blood sample from a patient, turn those cells into new retinal cells in a lab, and then transplant them back into the pa…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New eye cell transplant aims to halt blinding disease
Disease control Recruiting nowThis study is testing a new cell therapy called OpRegen for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes progressive vision loss. Doctors will inject the therapy under the retina during eye surgery to see if it is safe and i…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
One shot to halt blinding eye disease?
Disease control Recruiting nowThis study is testing a single injection into the eye to see if it is safe and can slow the progression of geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. It will involve about 104 participants aged 60 and older who have th…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Tracking a Vision-Saving injection in everyday eye care
Knowledge-focused Recruiting nowThis study aims to learn how doctors use an approved eye injection (avacincaptad pegol) to treat advanced macular degeneration in real-world clinics. It will observe 1,000 patients who have already decided with their doctor to start this treatment. The main goal is to collect inf…
Matched conditions: GEOGRAPHIC ATROPHY
Sponsor: Astellas Pharma Global Development, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC